Renibus Therapeutics Announces Participation at the Oppenheimer Private Life Sciences Company Showcase
SOUTHLAKE, Texas, Sept. 24, 2026 /PRNewswire/ -- Renibus Therapeutics® ("Renibus"), a clinical-stage biopharmaceutical company focusing on the prevention and treatment of cardio, renal and metabolic diseases, today announced its participation in the Oppenheimer Private Life Sciences...
Short extract only — this publisher licenses its text. Read the full release at the source.
More from Commercial newswire
- Allen Stanczak of Bad Ass Coffee of Hawaii Named IFA Franchisee of the Year
- Aberdeen Intermediate Income Fund (MIN) Announces Upcoming Reverse Stock Split
- How CU Anschutz Experts Diagnosed and Treated a Complex CSF Leak After Years of Misdiagnoses
The rest of this wire is for subscribers
Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
7 days, no card required.
Read releases like this the second they cross the wire.
1,400+ feeds — live on PPN World right now. Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
Start the free trial →Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live here.
PPN Source →